Y-mAbs Therapeutics, Inc. (YMAB)

NASDAQ: YMAB · Real-Time Price · USD

4.070

+0.180 (4.63%)

At close: May 12, 2025, 4:00 PM

4.070

0.00 (0.00%)

After-hours: May 12, 2025, 4:00 PM EDT

Y-mAbs Therapeutics Market Cap

Y-mAbs Therapeutics has a market cap or net worth of $184.04 million as of May 12, 2025. Its market cap has decreased by -72.51% in one year.

Market Cap

184.04M

Enterprise Value

109.48M

1-Year Change

-72.51%

Ranking

#3680

Market Cap Chart

Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $184.04M, a decrease of -76.90%. That is a compound annual growth rate of -19.82%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	175.90M	-49.84%
Dec 31, 2024	350.70M	17.88%
Dec 29, 2023	297.50M	39.61%
Dec 30, 2022	213.10M	-69.88%
Dec 31, 2021	707.47M	-64.73%
Dec 31, 2020	2.01B	61.56%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	659.45B
Johnson & Johnson	371.06B
UnitedHealth Group	345.29B
AbbVie	326.08B
Novo Nordisk	297.79B
Abbott Laboratories	231.82B
Novartis AG	214.71B
AstraZeneca	211.14B

Market Cap Rankings